PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 153 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $116,193 | -23.1% | 30,577 | +2.9% | 0.00% | -33.3% |
| Q4 2019 | $151,188 | +47.5% | 29,703 | +46.5% | 0.00% | +50.0% |
| Q3 2019 | $102,485 | -34.1% | 20,274 | -19.6% | 0.00% | -33.3% |
| Q2 2019 | $155,558 | +61.6% | 25,212 | +21.5% | 0.00% | +50.0% |
| Q1 2019 | $96,289 | -16.7% | 20,752 | -24.6% | 0.00% | 0.0% |
| Q4 2018 | $115,588 | -23.1% | 27,521 | +14.8% | 0.00% | -33.3% |
| Q3 2018 | $150,373 | -99.9% | 23,983 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $192,823,000 | +7.8% | 23,983 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $178,913,000 | +177041.6% | 23,983 | +41.8% | 0.00% | +200.0% |
| Q4 2017 | $101,000 | -69.2% | 16,908 | -65.0% | 0.00% | -50.0% |
| Q2 2017 | $328,000 | -28.1% | 48,263 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $456,000 | +14.9% | 48,263 | +5.0% | 0.00% | 0.0% |
| Q4 2016 | $397,000 | +27.7% | 45,972 | -6.3% | 0.00% | +50.0% |
| Q3 2016 | $311,000 | +46.7% | 49,074 | -2.2% | 0.00% | 0.0% |
| Q2 2016 | $212,000 | -3.2% | 50,187 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $219,000 | -28.9% | 50,187 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $308,000 | +18.9% | 50,187 | +10.6% | 0.00% | 0.0% |
| Q3 2015 | $259,000 | -29.4% | 45,367 | -7.8% | 0.00% | -33.3% |
| Q2 2015 | $367,000 | -9.4% | 49,204 | -8.1% | 0.00% | 0.0% |
| Q4 2014 | $405,000 | +45.7% | 53,538 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $278,000 | -8.9% | 53,538 | -24.3% | 0.00% | 0.0% |
| Q2 2014 | $305,000 | +5.5% | 70,728 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $289,000 | -15.7% | 70,728 | +9.8% | 0.00% | 0.0% |
| Q4 2013 | $343,000 | +65.7% | 64,419 | +56.5% | 0.00% | 0.0% |
| Q3 2013 | $207,000 | +12.5% | 41,169 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $184,000 | – | 41,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
| Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
| BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
| Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
| TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
| SEARLE & CO. | 60,000 | $349,000 | 0.34% |
| TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
| Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
| TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |